← Back to All Filings

Gilead CCO Sells $220K in GILD Stock for Tax Withholding

Low SignificanceDecember 11, 2025 at 6:32:13 PM EST

GILEAD SCIENCES, INC.

$GILD4CIK: 0000882095

Subscribe to track GILD

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Gilead CCO Sells $220K in GILD Stock for Tax Withholding

Company: GILEAD SCIENCES, INC. (GILD) Form: 4 | Filed: 2025/12/11 Significance: Low

Insider: Mercier Johanna Title: Chief Commercial Officer | Relationship: Officer

Transaction: • Type: Tax Withholding Sale • Shares: 1,814 • Price: $121.34 • Value: $220,112 • Owned After: 109,221

Key Insight: This was a non-discretionary sale to cover tax obligations from 3,842 vesting Restricted Stock Units (RSUs). Such transactions are routine and typically do not signal a change in insider sentiment.

Market Context: The transaction value represents less than 0.001% of Gilead's $155.11B market cap, confirming its low materiality.

Comprehensive Analysis

SEC Filing Analysis: GILEAD SCIENCES, INC. (GILD)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: A Gilead executive executed a routine, non-discretionary "sell-to-cover" transaction to satisfy tax liabilities arising from vesting equity awards.
  • Market Impact: The transaction is immaterial relative to the company's market capitalization and is not expected to impact the stock.

Company Information

FieldValue
CompanyGILEAD SCIENCES, INC.
Ticker SymbolGILD
CIK0000882095
IndustryBIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)

Insider Information

FieldValue
NameMercier Johanna
CIK0001782135
Title/PositionChief Commercial Officer
RelationshipOfficer

Transaction Details

This filing reports two key events: the vesting of Restricted Stock Units (RSUs) and a subsequent automatic sale to cover taxes.

FieldValue (Sell-to-Cover)
Form Type4
Transaction Date2025-12-10
Transaction CodeF (Payment of tax liability by withholding securities)
Security TypeCommon Stock
Shares Involved1,814
Price Per Share$121.34
Total Value$220,111.56
Shares Owned After109,221
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$220,111.56
% of Market Cap0.00014%
Shares Transacted1,814
% of Shares Outstanding0.00015%
Post-Transaction Ownership109,221 shares (0.0088% of outstanding)
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: For a mega-cap company like Gilead with a market capitalization of $155.11 billion, a transaction of ~$220k is negligible.
  • Ownership Concentration: The insider's post-transaction ownership of 109,221 shares remains a very small fraction of the total shares outstanding.
  • Dilution Impact: The underlying event was the vesting of 3,842 RSUs, representing 0.0003% of shares outstanding. This is a minimal dilution event, typical for executive compensation plans.
  • Transaction Significance: The sale was coded 'F', indicating it was an automatic transaction to cover taxes, not a discretionary sale based on the insider's market view. This, combined with the extremely low percentages of market cap and shares outstanding, confirms the low significance of this filing.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The transaction is a routine, automated sell-to-cover action required for tax purposes upon the vesting of equity. It does not reflect a voluntary investment decision by the insider.

Volume & Sentiment

  • Expected Volume Impact: None. The number of shares is insignificant compared to the stock's average daily trading volume.
  • Sentiment Indicator: Neutral. The market correctly interprets these 'F' coded transactions as procedural and not indicative of an insider's outlook on the company's future performance.

Additional Context

Transaction Notes

  • Vesting Event: The sale is directly linked to the vesting of 3,842 Restricted Stock Units (RSUs), which were converted into common stock (Transaction Code 'M'). The sale of 1,814 shares was to cover the associated tax liability.
Topics:#SECFiling#InsiderTrading#GILD#GileadSciences#Form4#StockMarket#Finance#ExecutiveTrade

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.